Highest-materiality recent filing
Synopsys appoints Elliott's Jesse Cohn to board under cooperation agreement
Jesse Cohn, Managing Partner at Elliott, appointed to Synopsys board effective June 1, 2026; board expands to 11.
Synopsys Q2 revenue $2.276B beats guidance; raises FY rev to $9.665B midpoint
Q2 revenue $2.276B (above prior guidance), up 42% YoY; non-GAAP EPS $3.35, GAAP EPS $0.09.
Synopsys shareholders approve amended equity plan extending awards to non-employee directors
Shareholders approved Amended and Restated Equity Incentive Plan on Apr 16, 2026; plan now allows non-employee directors to receive awards.
Synopsys enters $250M accelerated share repurchase agreement with Bank of Nova Scotia
Initial delivery of approximately 513,000 shares; final settlement by June 1, 2026.
Synopsys Q1 FY2026 revenue $2.409B, non-GAAP EPS $3.77; board authorizes $2B buyback
Revenue $2.409B (high-end of guidance); GAAP EPS $0.34, non-GAAP EPS $3.77 above guidance.
Synopsys appoints former Deloitte interim CEO Peter Shimer to board; Borgen, Gopal not renominated
Peter A. Shimer appointed to board and audit committee, effective Feb 14, 2026.
Synopsys posts record FY2025 revenue $7.054B; Q4 beats midpoint; FY2026 guidance $9.61B
Record full-year 2025 revenue $7.054B (+15% YoY); Q4 revenue $2.255B exceeded midpoint; Ansys contributed $667.7M.
Synopsys and NVIDIA announce strategic partnership; NVIDIA invests $2B in SNPS stock
NVIDIA purchased 4,821,717 shares of Synopsys common stock at $414.79/share for $2B cash.
Synopsys plans 10% workforce reduction; estimates $300M-$350M in pre-tax charges
Board approved restructuring on Nov 9, 2025; workforce reduction of ~10% of FY2025 year-end headcount.
Synopsys CRO Rick Mahoney departs effective immediately; FY2025 guidance reaffirmed
Rick Mahoney has left the role of Chief Revenue Officer, effective immediately on November 4, 2025; search for successor is advanced.
Synopsys appoints Vijayaraghavan to Board's Governance and Nominating Committee
Mr. Vijayaraghavan was appointed to the Board on July 17, 2025, as previously reported.
Synopsys Q3 FY2025 revenue up 14% to $1.74B; GAAP EPS $1.50 vs $2.73 YoY
Revenue $1.740B (+14% YoY); GAAP net income $242.5M ($1.50 diluted EPS) vs $425.9M ($2.73) YoY.
Synopsys completes acquisition of Ansys; exchange ratio adjusted, board adds two Ansys directors
Each Ansys share converted to ~0.34 Synopsys shares + ~$199.91 cash; ratio adjusted to stay under 19.999% issuance cap.
Synopsys receives all regulatory approvals for Ansys acquisition; closing expected July 17
All necessary regulatory approvals received for the pending acquisition of Ansys.
US Commerce Dept rescinds China export restrictions on Synopsys, effective July 2
BIS rescinded China-related export restrictions previously imposed on May 29, 2025, effective immediately.
Synopsys suspends FY2025 guidance after receiving new BIS China export restrictions
Received BIS letter on May 29, 2025 imposing new export restrictions related to China.
Synopsys Q2 revenue $1.604B, GAAP EPS $2.24, non-GAAP EPS $3.67; reaffirms FY2025 guidance
Revenue $1.604B (+10.2% YoY from $1.455B), exceeding midpoint of guidance.
Stockholders approved an amendment to the 2006 Employee Equity Incentive Plan to increase authorized shares by 1,600,000; vote 120.2M for, 5.7M against.
Issued $10B aggregate principal: $1B 4.550% notes due 2027, $1B 4.650% due 2028, $2B 4.850% due 2030, $1.5B 5.000% due 2032, $2.4B 5.150% due 2035, $2.1B 5.700% due 2055.
Synopsys raises $10B in senior notes offering to fund Ansys acquisition
Issued $10B in senior notes across six tranches: 2027 (4.55%), 2028 (4.65%), 2030 (4.85%), 2032 (5.00%), 2035 (5.15%), and 2055 (5.70%).
Synopsys files Ansys FY2024 audited financials and updated pro forma merger statements
Ansys FY2024 revenue $2.545B, net income $575.7M; FY2023 revenue $2.270B, net income $500.4M.
Synopsys Q1 revenue $1.455B, non-GAAP EPS $3.03; reaffirms FY2025 guidance
Q1 revenue $1.455B, down from $1.511B YoY; exceeded midpoint of guidance.
Synopsys Q4 FY24 revenue $1.636B, up 11% YoY; non-GAAP EPS $3.40 beats guidance
Record quarterly revenue $1.636B, up ~11% YoY; full-year revenue $6.127B, up ~15% YoY.
Synopsys changes fiscal year-end to Oct 31; quarterly periods shift to calendar month-ends
Board approved change from 52/53-week fiscal year ending Sat near Oct 31 to Oct 31 calendar date, effective FY2025.
Synopsys completes sale of Software Integrity unit to Clearlake and Francisco Partners
Sale completed on Sept 30, 2024; buyers are entities controlled by Clearlake Capital and Francisco Partners.
Synopsys Q3 FY2024 revenue record $1.526B, non-GAAP EPS $3.43 beat guidance
Record Q3 revenue $1.526B (+13% YoY); GAAP EPS $2.73; non-GAAP EPS $3.43 (+27% YoY).
Submitted transaction notification to China's State Administration for Market Regulation on July 10, 2024.
Synopsys Q2 revenue $1.455B (+15% YoY), non-GAAP EPS $3.00 (+26%); raises FY2024 targets
GAAP net income $299.1M ($1.92/diluted share); non-GAAP net income $466.9M ($3.00/diluted share), beating guidance.
China regulator says Synopsys must notify Ansys deal despite below threshold; closing H1 2025
On May 14, 2024, Synopsys received notice from China's SAMR that the Ansys acquisition is below Chinese merger notification thresholds but Synopsys is required to notify the transaction.
Synopsys to sell Software Integrity business to Clearlake/Francisco Partners for up to $2.1B
Total consideration up to $2.1B: $1.5B at closing; $125M deferred over 5 quarters; up to $475M earnout tied to liquidity event rate of return.
Synopsys shareholders approve 3.4M share increase to equity plan; reject independent chair proposal
Stockholders approved amendment to 2006 Employee Equity Incentive Plan, increasing share pool by 3,400,000 shares.
Synopsys amends bylaws to let independent directors appoint lead independent director
Lead independent director will be appointed solely by the independent directors, not the full board.
Synopsys initiates sale process for Software Integrity business
Board of Directors approved initiation of sale process for Software Integrity business after strategic review.
Synopsys and Ansys agree to add Ansys CEO Ajei Gopal to Synopsys board post-merger
Dr. Ajei Gopal, Ansys President and CEO since 2017, to join Synopsys board upon acquisition close.
Synopsys Q1 FY2024 revenue $1.65B (+21% YoY); GAAP EPS $2.89; non-GAAP EPS $3.56 above guidance
Record quarterly revenue of $1.649B, up ~21% YoY; GAAP net income $449.1M ($2.89 diluted EPS).
Synopsys signs $4.3B term loan for Ansys acquisition, amends $850M revolver
Sixth Amendment to $850M revolver adjusts financial covenants for Ansys Merger; no outstanding balance.
Synopsys to acquire Ansys for 0.345 shares plus $197 cash per share
Each Ansys share converts to 0.3450 Synopsys shares and $197 cash; Ansys shareholders to own ~16.5% of combined company.
Ghazi becomes CEO on Jan 1, 2024; base salary $840k, target bonus 200% of base.
Synopsys amends bylaws: lowers special meeting threshold to 15% of outstanding shares
Reduced requisite percentage to call special stockholder meeting from 20% to 15% of outstanding shares.
Synopsys Q4 revenue $1.599B (+25% YoY), non-GAAP EPS $3.17 beats guidance
Record quarterly revenue of $1.599B, up ~25% YoY; FY revenue $5.843B, up ~15% YoY.
Synopsys appoints Mr. Painter to Corporate Governance and Nominating Committee
Mr. Painter appointed to Synopsys Board on August 4, 2023.
Synopsys enters $300M accelerated share repurchase agreement with Wells Fargo
ASR with Wells Fargo Bank, NA to repurchase $300M of Synopsys common stock.
Record quarterly revenue of $1.487B, up 19% YoY; GAAP EPS $2.17 vs $1.43 last year.
Synopsys CEO Aart de Geus to step down Jan 1, 2024; COO Sassine Ghazi to become CEO
Sassine Ghazi promoted from President/COO to President and CEO, effective Jan 1, 2024; also appointed to board Aug 13, 2023.
Synopsys appoints Trimble CEO Rob Painter to Board of Directors
Board expanded from 9 to 10; Painter appointed effective August 4, 2023.
Synopsys to hold annual Say-on-Pay votes through 2029
At April 12, 2023 annual meeting, shareholders indicated preference for annual Say-on-Pay votes.
Synopsys initiates $300M accelerated share repurchase with Mizuho
ASR with Mizuho Markets Americas LLC to repurchase $300M of Synopsys common stock.
Synopsys Q2 revenue $1.395B, non-GAAP EPS $2.54; raises FY guidance
Revenue $1.395B, up 9% YoY from $1.279B; exceeded all guidance targets.
Synopsys shareholders increase equity plan shares by 3.3M, approve special meeting proposal
Stockholders approved 3,300,000 share increase under 2006 Employee Equity Incentive Plan; 115.67M for, 10.88M against.
Synopsys enters $300M accelerated share repurchase agreement with Bank of America
Initial delivery of ~718,000 shares; remainder settled by May 12, 2023.
There are no arrangements or understandings between Mr. Cohn and any other person pursuant to which Mr. Cohn was appointed as a director
and appointed Dr. de Geus to the role of Executive Chairperson of the Board
the Board promoted Mr. Ghazi, Synopsys’ President and Chief Operating Officer, to the role of President and Chief Executive Officer
On August 13, 2023, the Board also approved an increase in the size of the Board from ten to eleven directors, and appointed Mr. Ghazi as a director, in each case, effective as of August 13, 2023.
On August 12, 2023, Aart J. de Geus informed the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) of his intent to step down as Chief Executive Officer of Synopsys, effective January 1, 2024 (the “ Effective Date ”). In connection therewith, on August 13, 2023, the Board promoted Sassine Ghazi, Synopsys’ President and Chief Operating Officer, to the role of President and Chief Executive Officer, and appointed Dr. de Geus to the role of Executive Chair of the Board, in each case, effective as of the Effective Date.
the Board promoted Sassine Ghazi, Synopsys’ President and Chief Operating Officer, to the role of President and Chief Executive Officer
Trac Pham will cease serving as Chief Financial Officer of Synopsys, effective as of the Effective Date, and will continue in an executive advisor role through December 2022 to ensure an orderly transition.
On November 28, 2022, the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) appointed Shelagh Glaser as Chief Financial Officer of Synopsys, effective as of December 2, 2022
the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) increased the size of the Board from eight to ten directors and appointed Luis Borgen and Marc Casper (each an “ Appointee ” and together, the “ Appointees ”) to serve as directors effective immediately.
the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) increased the size of the Board from eight to ten directors and appointed Luis Borgen and Marc Casper (each an “ Appointee ” and together, the “ Appointees ”) to serve as directors effective immediately.
On May 13, 2022, Joseph Logan notified Synopsys, Inc. of his decision to transition from his role as Chief Revenue Officer at the conclusion of fiscal year 2022.
On November 28, 2021, Trac Pham notified Synopsys, Inc. (“ Synopsys ”) that he intends to retire as Chief Financial Officer of Synopsys in 2022.
Max materiality 1.00 · Median 0.68 · Most common event other_material